|Articles|September 9, 2021
Positioning Biobanking Assets for Maximum Value
Author(s)Crosstree
As precision medicine grows, so, too, does demand for biobanking services, offering both strategic and financial investors a significant opportunity for value creation.
Related Content
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
The New Healthy Aging Imperative and What It Means for Pharma
4
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
5